NCT03901664

Brief Summary

To determine if artificial intelligence allow to detect lymphocyte subpopulations specific of diseases (such as primary Sjogren' syndrome and systemic lupus erythematosus) among patients with suspicion of autoimmune diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2018

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 3, 2019

Completed
Last Updated

April 3, 2019

Status Verified

September 1, 2018

Enrollment Period

2 months

First QC Date

December 4, 2018

Last Update Submit

April 2, 2019

Conditions

Autoimmune Diseases

Outcome Measures

Primary Outcomes (1)

  • Diagnosis of autoimmune disease

    Diagnosis (systemic lupus erythematosus, primary Sjopgren's ....) according to current ACR/EULAR criteria

    an average of 1 year

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

autoimmune diseases (lupus and Sjogren's) or chonic infection (Whipple's disease)

You may qualify if:

  • autoimmune or infectious disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de Brest

Brest, 29609, France

Location

MeSH Terms

Conditions

Autoimmune Diseases

Condition Hierarchy (Ancestors)

Immune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2018

First Posted

April 3, 2019

Study Start

February 1, 2018

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

April 3, 2019

Record last verified: 2018-09

Locations

FR(1)